Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:44 PM
Ignite Modification Date:
2025-12-24 @ 5:44 PM
NCT ID:
NCT01174368
Eligibility Criteria:
Inclusion Criteria:
* Cancer of prostate
* Evidence of metastasis
* Failed available therapies
* Resolution of any toxic effects of previous therapies
* Performance status (ECOG PS) 0-2
* Adequate hematologic, coagulation (INR 2-3max), hepatic and renal function
* Life expectancy of 12 months
* Agrees to contraceptive use while on study if sexually active
* Sign informed consent document
Exclusion Criteria:
* Any condition presenting an unacceptably high anesthetic or surgical risk
* HIV positive
* Cognitive impairment such as to preclude informed consent
* Other surgical treatment, chemotherapy and radiation within four weeks of baseline
* Inadequate hematologic, coagulation (INR \>3), hepatic, renal function
* Hepatic blood flow abnormalities and/or large-volume ascites
* Concurrent cancer of any other type except skin cancer (excluding melanoma)
* History of allergic reactions to mouse antigens
* Active infection, congestive heart failure, unstable angina, serious cardiac arrhythmias, psychiatric illness, difficult social situations not permitting reliable participation, active bleeding
Healthy Volunteers:
False
Sex:
MALE
Minimum Age:
18 Years
Study:
NCT01174368
Study Brief:
Protocol Section:
NCT01174368